share_log

PetMed Express Analyst Ratings

PetMed Express Analyst Ratings

PetMed Express
Benzinga ·  2023/10/31 20:40
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/31/2023 3.4% Morgan Stanley $10 → $7 Maintains Underweight
10/19/2023 47.71% Morgan Stanley $17 → $10 Maintains Underweight
07/27/2023 151.11% Morgan Stanley $17 → $17 Reiterates Underweight → Underweight
05/25/2023 195.42% Lake Street → $20 Initiates Coverage On → Buy
03/23/2023 151.11% Morgan Stanley $18 → $17 Maintains Underweight
11/08/2022 165.88% Morgan Stanley $19 → $18 Maintains Underweight
07/26/2022 180.65% Morgan Stanley $20 → $19 Maintains Underweight
05/10/2022 195.42% Morgan Stanley $21 → $20 Maintains Underweight
01/25/2022 210.19% Morgan Stanley $25 → $21 Maintains Underweight
01/20/2022 372.67% Sidoti & Co. → $32 Upgrades Neutral → Buy
11/18/2021 269.28% Morgan Stanley → $25 Initiates Coverage On → Underweight
10/01/2021 313.59% Jefferies → $28 Initiates Coverage On → Hold
06/03/2021 476.07% Sidoti & Co. → $39 Downgrades Buy → Neutral
03/05/2021 Sidoti & Co. Upgrades Neutral → Buy
08/19/2020 505.61% Sidoti & Co. $37 → $41 Upgrades Neutral → Buy
02/24/2020 Sidoti & Co. Downgrades Buy → Neutral
10/17/2019 195.42% Craig-Hallum $15 → $20 Maintains Hold
08/16/2019 Craig-Hallum Downgrades Buy → Hold
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月31日 3.4% 摩根士丹利 $10→$7 維護 體重不足
2023年10月19日 47.71% 摩根士丹利 $17→$10 維護 體重不足
07/27/2023 151.11% 摩根士丹利 $17→$17 重申 減碼→減碼
2023年05月25日 195.42% 萊克街 →$20 開始承保 →購買
03/23/2023 151.11% 摩根士丹利 $18→$17 維護 體重不足
11/08/2022 165.88% 摩根士丹利 $19→$18 維護 體重不足
07/26/2022 180.65% 摩根士丹利 $20→$19 維護 體重不足
2022年05月10日 195.42% 摩根士丹利 $21→$20 維護 體重不足
01/25/2022 210.19% 摩根士丹利 $25→$21 維護 體重不足
01/20/2022 372.67% 西多蒂公司 →$32 升級 中性→購買
2021年11月18日 269.28% 摩根士丹利 →$25 開始承保 →減持
10/01/2021 313.59% 傑富瑞 →$28 開始承保 →保留
06/03/2021 476.07% 西多蒂公司 →$39 評級下調 購買→中性
03/05/2021 - 西多蒂公司 升級 中性→購買
2020年08月19日 505.61% 西多蒂公司 $37→$41 升級 中性→購買
02/24/2020 - 西多蒂公司 評級下調 購買→中性
2019年10月17日 195.42% 克雷格-哈勒姆 $15→$20 維護 保持
2019年8月16日 - 克雷格-哈勒姆 評級下調 購買→Hold

What is the target price for PetMed Express (PETS)?

PetMed Express(寵物)的目標價格是多少?

The latest price target for PetMed Express (NASDAQ: PETS) was reported by Morgan Stanley on October 31, 2023. The analyst firm set a price target for $7.00 expecting PETS to rise to within 12 months (a possible 3.40% upside). 6 analyst firms have reported ratings in the last year.

納斯達克(納斯達克:PETS)2023年10月31日報道了PetMed Express的最新目標價。這家分析公司設定的目標價格為7.00美元,預計寵物價格將在12個月內上漲(可能上漲3.40%)。6家分析公司在過去一年公佈了評級。

What is the most recent analyst rating for PetMed Express (PETS)?

PetMed Express(PETS)的最新分析師評級是多少?

The latest analyst rating for PetMed Express (NASDAQ: PETS) was provided by Morgan Stanley, and PetMed Express maintained their underweight rating.

納斯達克股票代碼:PETS)的最新分析師評級由摩根士丹利提供,PetMed Express維持其減持評級。

When is the next analyst rating going to be posted or updated for PetMed Express (PETS)?

PetMed Express(PETS)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與PetMed Express的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。PetMed Express的上一次評級是在2023年10月31日提交的,所以你應該預計下一次評級將在2024年10月31日左右的某個時候公佈。

Is the Analyst Rating PetMed Express (PETS) correct?

分析師對PetMed Express(PETS)的評級正確嗎?

While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $10.00 to $7.00. The current price PetMed Express (PETS) is trading at is $6.77, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的PetMed Express(PETS)評級維持不變,目標價在10.00美元至7.00美元之間。PetMed Express目前的交易價格為6.77美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論